Huo H, Feng Y, Tang Q. Correction to: Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy. Cancer Chemother Pharmacol 2024 Mar 26. doi: 10.1007/s00280-024-04646.
PMID: 38530444